AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $3,750,000 | -7.1% | 197,658 | -21.0% | 0.02% | -10.7% |
Q2 2016 | $4,035,000 | +21.6% | 250,331 | -9.5% | 0.03% | +7.7% |
Q1 2016 | $3,318,000 | -15.7% | 276,472 | 0.0% | 0.03% | -25.7% |
Q4 2015 | $3,934,000 | +45.2% | 276,472 | +19.2% | 0.04% | +34.6% |
Q3 2015 | $2,710,000 | – | 231,862 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |